Another bit of good news for generic approvals! June unofficially recorded seventy‑five full‑approval actions and thirteen tentative‑approval actions for a total of eighty‑eight approval actions for the month. The seventy‑five full approvals represent the second highest number of full‑approval actions in a month thus far this FY, with the big daddy still being March with ninety‑six full‑approval actions.
June represents the end of the third quarter and, once the official numbers are released, we will provide estimates of how the full FY will look. You can track approvals through the FDA’s All Approvals list (here). Just select the month and year of interest.
Hope you all have a great weekend and, for those of you in the Southeast, watch out for the Saharan dust storm (here) set to hit sometime this weekend!
